Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$578M |
| 2 |
Micron Technology
MU
|
+$433M |
| 3 |
Advanced Micro Devices
AMD
|
+$404M |
| 4 |
Amazon
AMZN
|
+$398M |
| 5 |
Accenture
ACN
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$777M |
| 2 |
Meta Platforms (Facebook)
META
|
+$752M |
| 3 |
Tesla
TSLA
|
+$627M |
| 4 |
Chevron
CVX
|
+$528M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.4% |
| 2 | Technology | 18.51% |
| 3 | Consumer Staples | 10.15% |
| 4 | Consumer Discretionary | 9.67% |
| 5 | Financials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Educational Development Corp
EDUC
$11.8M
| $653K | ﹤0.01% |
270,945
-24,181
| -8% | -$79.1K |
|
2752
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.4B
| $653K | ﹤0.01% |
+9,200
| New | +$725K |
|
2753
Hope Bancorp
HOPE
$1.78B
| $653K | ﹤0.01% |
51,700
-25,200
| -33% | -$365K |
|
2754
Comstock Holding Companies
CHCI
$154M
| $652K | ﹤0.01% |
164,264
-16,900
| -9% | -$74.4K |
|
2755
RPC Inc
RES
$1.31B
| $651K | ﹤0.01% |
94,000
-267,219
| -74% | -$1.94M |
|
2756
Cardiff Oncology
CRDF
$74.7M
| $650K | ﹤0.01% |
421,988
-305,628
| -42% | -$736K |
|
2757
Dare Bioscience
DARE
$19.9M
| $650K | ﹤0.01% |
54,167
+23,617
| +77% | +$324K |
|
2758
Verastem
VSTM
$519M
| $650K | ﹤0.01% |
63,698
+34,956
| +122% | +$488K |
|
|
AAIC
2759
DELISTED
Arlington Asset Investment Corp.
AAIC
| $650K | ﹤0.01% |
239,049
-22,500
| -9% | -$71.1K |
|
|
JCTC
2760
Jewett-Cameron Trading
JCTC
$9.86M
| $649K | ﹤0.01% |
122,528
-15,400
| -11% | -$95.9K |
|
2761
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$146M
| $647K | ﹤0.01% |
+1,906
| New | +$631K |
|
|
VBIV
2762
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $647K | ﹤0.01% |
30,533
+4,216
| +16% | +$114K |
|
|
NBP
2763
NovaBridge Biosciences American Depositary Shares
NBP
$197M
| $646K | ﹤0.01% |
+161,100
| New | +$1.22M |
|
2764
NerdWallet
NRDS
$582M
| $646K | ﹤0.01% |
72,800
-4,000
| -5% | -$39.2K |
|
2765
Orion Group Holdings
ORN
$410M
| $646K | ﹤0.01% |
244,797
-17,700
| -7% | -$46.5K |
|
2766
Trevi Therapeutics
TRVI
$2.63B
| $646K | ﹤0.01% |
419,187
+267,687
| +177% | +$878K |
|
2767
Garrett Motion
GTX
$5.68B
| $642K | ﹤0.01% |
113,700
+33,300
| +41% | +$229K |
|
2768
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.84B
| $641K | ﹤0.01% |
22,000
+4,500
| +26% | +$146K |
|
2769
Woori Financial
WF
$17.1B
| $641K | ﹤0.01% |
28,700
+2,600
| +10% | +$68.3K |
|
2770
Nu Holdings
NU
$68.2B
| $640K | ﹤0.01% |
+145,400
| New | +$667K |
|
2771
Willamette Valley Vineyards
WVVI
$12M
| $640K | ﹤0.01% |
103,752
-19,700
| -16% | -$124K |
|
|
SGMA
2772
DELISTED
Sigmatron International
SGMA
| $638K | ﹤0.01% |
134,287
-12,700
| -9% | -$90K |
|
|
SPYM
2773
State Street SPDR Portfolio S&P 500 ETF
SPYM
$167B
| $638K | ﹤0.01% |
+15,200
| New | +$710K |
|
|
BCEL
2774
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $637K | ﹤0.01% |
405,877
-154,923
| -28% | -$318K |
|
2775
CS Disco
LAW
$282M
| $635K | ﹤0.01% |
63,500
+46,314
| +269% | +$842K |
|
Similar funds
Renaissance Technologies's Q3 2022 Portfolio in Review
As of Q3 2022, Renaissance Technologies held 4,619 positions worth $70.7B, down 16% from $84.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $8.71B in Q3 2022, closing 637 positions and reducing 2,164 holdings. Its most notable exit was Shopify, an estimated $439M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class A worth $498M.
- Renaissance Technologies's largest Q3 2022 buy was Alphabet (Google) Class A: 5,208,460 shares worth $498M.
- Renaissance Technologies added most to Advanced Micro Devices in Q3 2022, an estimated $404M increase.
- Renaissance Technologies's biggest Q3 2022 reduction was Apple, cutting an estimated $777M.
- Renaissance Technologies fully exited Shopify in Q3 2022, selling an estimated $439M.
- Renaissance Technologies's ten largest holdings make up 11% of its $70.7B portfolio in Q3 2022.
- Renaissance Technologies opened 441 new positions and closed 637 in Q3 2022.
- Renaissance Technologies's portfolio value fell 16% quarter-over-quarter to $70.7B.
Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.